ID   GLRX3_HUMAN             Reviewed;         335 AA.
AC   O76003; B3KMP7; B3KMQ5; D3DRG2; Q5JV01; Q96CE0; Q9P1B0; Q9P1B1;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2003, sequence version 2.
DT   07-APR-2021, entry version 204.
DE   RecName: Full=Glutaredoxin-3;
DE   AltName: Full=PKC-interacting cousin of thioredoxin {ECO:0000303|PubMed:10636891};
DE            Short=PICOT {ECO:0000303|PubMed:10636891};
DE   AltName: Full=PKC-theta-interacting protein;
DE            Short=PKCq-interacting protein;
DE   AltName: Full=Thioredoxin-like protein 2;
GN   Name=GLRX3; Synonyms=PICOT {ECO:0000303|PubMed:10636891}, TXNL2;
GN   ORFNames=HUSSY-22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, INTERACTION WITH PRKCQ,
RP   AND VARIANTS HIS-21 AND SER-123.
RC   TISSUE=Liver, Spleen, and T-cell lymphoma;
RX   PubMed=10636891; DOI=10.1074/jbc.275.3.1902;
RA   Witte S., Villalba M., Bi K., Liu Y., Isakov N., Altman A.;
RT   "Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by
RT   PICOT, a novel protein kinase C-interacting protein with a thioredoxin
RT   homology domain.";
RL   J. Biol. Chem. 275:1902-1909(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Melanocyte;
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::aid-yea647>3.0.co;2-h;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B., Cannata N.,
RA   Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to yeast
RT   sequences.";
RL   Yeast 18:69-80(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-21 AND SER-123.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-21 AND SER-123.
RC   TISSUE=Bone marrow, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 59-79; 115-130; 218-231; 246-253; 309-319 AND 323-332.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   SUBUNIT, MUTAGENESIS OF CYS-159 AND CYS-261, AND METAL.
RX   PubMed=20226171; DOI=10.1016/j.bbrc.2010.03.016;
RA   Haunhorst P., Berndt C., Eitner S., Godoy J.R., Lillig C.H.;
RT   "Characterization of the human monothiol glutaredoxin 3 (PICOT) as iron-
RT   sulfur protein.";
RL   Biochem. Biophys. Res. Commun. 394:372-376(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   INTERACTION WITH BOLA2.
RX   PubMed=22309771; DOI=10.1021/bi2019089;
RA   Li H., Mapolelo D.T., Randeniya S., Johnson M.K., Outten C.E.;
RT   "Human glutaredoxin 3 forms [2Fe-2S]-bridged complexes with human BolA2.";
RL   Biochemistry 51:1687-1696(2012).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117 AND SER-120, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   FUNCTION.
RX   PubMed=23615448; DOI=10.1091/mbc.e12-09-0648;
RA   Haunhorst P., Hanschmann E.M., Brautigam L., Stehling O., Hoffmann B.,
RA   Muhlenhoff U., Lill R., Berndt C., Lillig C.H.;
RT   "Crucial function of vertebrate glutaredoxin 3 (PICOT) in iron homeostasis
RT   and hemoglobin maturation.";
RL   Mol. Biol. Cell 24:1895-1903(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH BOLA2.
RX   PubMed=26613676; DOI=10.1021/jacs.5b10592;
RA   Banci L., Camponeschi F., Ciofi-Baffoni S., Muzzioli R.;
RT   "Elucidating the molecular function of human BOLA2 in GRX3-dependent
RT   anamorsin maturation pathway.";
RL   J. Am. Chem. Soc. 137:16133-16143(2015).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH BOLA2, AND
RP   MUTAGENESIS OF CYS-159; 159-TRP-PRO-160; CYS-261 AND 299-TRP-PRO-300.
RX   PubMed=27519415; DOI=10.1074/jbc.m116.744946;
RA   Frey A.G., Palenchar D.J., Wildemann J.D., Philpott C.C.;
RT   "A glutaredoxin-BolA complex serves as an iron-sulfur cluster chaperone for
RT   the cytosolic cluster assembly machinery.";
RL   J. Biol. Chem. 291:22344-22356(2016).
RN   [19]
RP   STRUCTURE BY NMR OF 1-119.
RG   RIKEN structural genomics initiative (RSGI);
RT   "The solution structure of the thioredoxin domain of human thioredoxin-like
RT   protein 2.";
RL   Submitted (APR-2007) to the PDB data bank.
CC   -!- FUNCTION: Together with BOLA2, acts as a cytosolic iron-sulfur (Fe-S)
CC       cluster assembly factor that facilitates [2Fe-2S] cluster insertion
CC       into a subset of cytosolic proteins (PubMed:26613676, PubMed:27519415).
CC       Acts as a critical negative regulator of cardiac hypertrophy and a
CC       positive inotropic regulator (By similarity). Required for hemoglobin
CC       maturation (PubMed:23615448). Does not possess any thyoredoxin activity
CC       since it lacks the conserved motif that is essential for catalytic
CC       activity. {ECO:0000250|UniProtKB:Q9CQM9, ECO:0000269|PubMed:23615448,
CC       ECO:0000269|PubMed:26613676, ECO:0000269|PubMed:27519415}.
CC   -!- SUBUNIT: Homodimer; the homodimer is independent of 2Fe-2S clusters
CC       (PubMed:27519415). Heterotrimer; forms a heterotrimeric complex
CC       composed by two BOLA2 molecules and one GLRX3 molecule; linked by [2Fe-
CC       2S] clusters (PubMed:22309771, PubMed:26613676, PubMed:27519415).
CC       Interacts (via N-terminus) with PRKCQ/PKC-theta (PubMed:10636891).
CC       Interacts (via C-terminus) with CSRP3 (By similarity). Interacts with
CC       CSRP2 (By similarity). {ECO:0000250|UniProtKB:Q9CQM9,
CC       ECO:0000269|PubMed:10636891, ECO:0000269|PubMed:22309771,
CC       ECO:0000269|PubMed:26613676, ECO:0000269|PubMed:27519415}.
CC   -!- INTERACTION:
CC       O76003; P82987: ADAMTSL3; NbExp=3; IntAct=EBI-374781, EBI-10221726;
CC       O76003; Q96Q83: ALKBH3; NbExp=3; IntAct=EBI-374781, EBI-6658697;
CC       O76003; Q9Y3E2: BOLA1; NbExp=14; IntAct=EBI-374781, EBI-1049556;
CC       O76003; A0A087WZT3: BOLA2B; NbExp=3; IntAct=EBI-374781, EBI-12006120;
CC       O76003; Q53S33: BOLA3; NbExp=5; IntAct=EBI-374781, EBI-12086950;
CC       O76003; Q16790: CA9; NbExp=9; IntAct=EBI-374781, EBI-12259996;
CC       O76003; Q13191: CBLB; NbExp=3; IntAct=EBI-374781, EBI-744027;
CC       O76003; Q86Y33-5: CDC20B; NbExp=3; IntAct=EBI-374781, EBI-11983537;
CC       O76003; Q5T4B2: CERCAM; NbExp=3; IntAct=EBI-374781, EBI-12261896;
CC       O76003; Q9UFW8: CGGBP1; NbExp=3; IntAct=EBI-374781, EBI-723153;
CC       O76003; Q6FI81: CIAPIN1; NbExp=18; IntAct=EBI-374781, EBI-750511;
CC       O76003; Q6FI81-1: CIAPIN1; NbExp=2; IntAct=EBI-374781, EBI-16172762;
CC       O76003; P27658: COL8A1; NbExp=3; IntAct=EBI-374781, EBI-747133;
CC       O76003; Q9NWS6: FAM118A; NbExp=3; IntAct=EBI-374781, EBI-8638992;
CC       O76003; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-374781, EBI-10172181;
CC       O76003; O76003: GLRX3; NbExp=2; IntAct=EBI-374781, EBI-374781;
CC       O76003; Q9P2W3: GNG13; NbExp=3; IntAct=EBI-374781, EBI-11427343;
CC       O76003; P28799: GRN; NbExp=9; IntAct=EBI-374781, EBI-747754;
CC       O76003; Q9BQS7-3: HEPH; NbExp=3; IntAct=EBI-374781, EBI-22734368;
CC       O76003; Q9H2F3: HSD3B7; NbExp=3; IntAct=EBI-374781, EBI-3918847;
CC       O76003; Q13422: IKZF1; NbExp=3; IntAct=EBI-374781, EBI-745305;
CC       O76003; P22301: IL10; NbExp=3; IntAct=EBI-374781, EBI-1031632;
CC       O76003; P78412: IRX6; NbExp=5; IntAct=EBI-374781, EBI-12100506;
CC       O76003; Q8NEP7: KLHDC9; NbExp=5; IntAct=EBI-374781, EBI-12214879;
CC       O76003; Q5T749: KPRP; NbExp=3; IntAct=EBI-374781, EBI-10981970;
CC       O76003; Q15323: KRT31; NbExp=3; IntAct=EBI-374781, EBI-948001;
CC       O76003; O76015: KRT38; NbExp=3; IntAct=EBI-374781, EBI-1047263;
CC       O76003; P60412: KRTAP10-11; NbExp=4; IntAct=EBI-374781, EBI-10217483;
CC       O76003; P60370: KRTAP10-5; NbExp=6; IntAct=EBI-374781, EBI-10172150;
CC       O76003; P60410: KRTAP10-8; NbExp=8; IntAct=EBI-374781, EBI-10171774;
CC       O76003; P60411: KRTAP10-9; NbExp=8; IntAct=EBI-374781, EBI-10172052;
CC       O76003; P60328: KRTAP12-3; NbExp=3; IntAct=EBI-374781, EBI-11953334;
CC       O76003; Q9BYQ6: KRTAP4-11; NbExp=8; IntAct=EBI-374781, EBI-10302392;
CC       O76003; Q9BQ66: KRTAP4-12; NbExp=7; IntAct=EBI-374781, EBI-739863;
CC       O76003; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-374781, EBI-10172511;
CC       O76003; Q9BYR3: KRTAP4-4; NbExp=3; IntAct=EBI-374781, EBI-11958132;
CC       O76003; Q9BYR2: KRTAP4-5; NbExp=5; IntAct=EBI-374781, EBI-11993254;
CC       O76003; Q9BYR0: KRTAP4-7; NbExp=3; IntAct=EBI-374781, EBI-10302547;
CC       O76003; Q6L8G4: KRTAP5-11; NbExp=3; IntAct=EBI-374781, EBI-11993296;
CC       O76003; Q6L8H2: KRTAP5-3; NbExp=7; IntAct=EBI-374781, EBI-11974251;
CC       O76003; Q6L8H1: KRTAP5-4; NbExp=3; IntAct=EBI-374781, EBI-11963072;
CC       O76003; Q6L8G9: KRTAP5-6; NbExp=7; IntAct=EBI-374781, EBI-10250562;
CC       O76003; P26371: KRTAP5-9; NbExp=8; IntAct=EBI-374781, EBI-3958099;
CC       O76003; Q9BYQ4: KRTAP9-2; NbExp=8; IntAct=EBI-374781, EBI-1044640;
CC       O76003; Q9BYQ3: KRTAP9-3; NbExp=3; IntAct=EBI-374781, EBI-1043191;
CC       O76003; Q9BYQ0: KRTAP9-8; NbExp=3; IntAct=EBI-374781, EBI-11958364;
CC       O76003; Q5TA82: LCE2D; NbExp=6; IntAct=EBI-374781, EBI-10246750;
CC       O76003; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-374781, EBI-739832;
CC       O76003; O60336: MAPKBP1; NbExp=6; IntAct=EBI-374781, EBI-947402;
CC       O76003; P53582: METAP1; NbExp=3; IntAct=EBI-374781, EBI-1051435;
CC       O76003; Q6UVY6: MOXD1; NbExp=7; IntAct=EBI-374781, EBI-7134667;
CC       O76003; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-374781, EBI-945833;
CC       O76003; P34130: NTF4; NbExp=3; IntAct=EBI-374781, EBI-3907456;
CC       O76003; Q96PB7: OLFM3; NbExp=3; IntAct=EBI-374781, EBI-10292253;
CC       O76003; Q92824: PCSK5; NbExp=3; IntAct=EBI-374781, EBI-751290;
CC       O76003; Q99471: PFDN5; NbExp=3; IntAct=EBI-374781, EBI-357275;
CC       O76003; O15162: PLSCR1; NbExp=4; IntAct=EBI-374781, EBI-740019;
CC       O76003; Q04759: PRKCQ; NbExp=5; IntAct=EBI-374781, EBI-374762;
CC       O76003; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-374781, EBI-1504830;
CC       O76003; Q6P9E2: RECK; NbExp=3; IntAct=EBI-374781, EBI-10253121;
CC       O76003; O76081: RGS20; NbExp=4; IntAct=EBI-374781, EBI-1052678;
CC       O76003; O76081-6: RGS20; NbExp=3; IntAct=EBI-374781, EBI-10178530;
CC       O76003; Q92922: SMARCC1; NbExp=3; IntAct=EBI-374781, EBI-355653;
CC       O76003; Q9BT81: SOX7; NbExp=3; IntAct=EBI-374781, EBI-7239117;
CC       O76003; O95793: STAU1; NbExp=3; IntAct=EBI-374781, EBI-358174;
CC       O76003; Q9BX79-6: STRA6; NbExp=3; IntAct=EBI-374781, EBI-12140683;
CC       O76003; P15884: TCF4; NbExp=3; IntAct=EBI-374781, EBI-533224;
CC       O76003; O95988: TCL1B; NbExp=5; IntAct=EBI-374781, EBI-727338;
CC       O76003; Q86YD3: TMEM25; NbExp=4; IntAct=EBI-374781, EBI-10260688;
CC       O76003; Q13077: TRAF1; NbExp=5; IntAct=EBI-374781, EBI-359224;
CC       O76003; Q9NQ86: TRIM36; NbExp=6; IntAct=EBI-374781, EBI-2341518;
CC       O76003; Q8IWZ5: TRIM42; NbExp=6; IntAct=EBI-374781, EBI-5235829;
CC       O76003; Q16851: UGP2; NbExp=3; IntAct=EBI-374781, EBI-743729;
CC       O76003; Q8NCP5: ZBTB44; NbExp=3; IntAct=EBI-374781, EBI-5658292;
CC       O76003; Q15973: ZNF124; NbExp=3; IntAct=EBI-374781, EBI-2555767;
CC       O76003; Q9UQR1: ZNF148; NbExp=3; IntAct=EBI-374781, EBI-2688184;
CC       O76003; Q86VK4-3: ZNF410; NbExp=3; IntAct=EBI-374781, EBI-11741890;
CC       O76003; Q9BUY5: ZNF426; NbExp=3; IntAct=EBI-374781, EBI-743265;
CC       O76003; Q9ULM2: ZNF490; NbExp=3; IntAct=EBI-374781, EBI-1105370;
CC       O76003; Q6NX49: ZNF544; NbExp=3; IntAct=EBI-374781, EBI-2841978;
CC       O76003; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-374781, EBI-10251462;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:27519415}.
CC       Cytoplasm, cell cortex {ECO:0000269|PubMed:10636891}. Cytoplasm,
CC       myofibril, sarcomere, Z line {ECO:0000250|UniProtKB:Q9CQM9}. Note=Under
CC       the plasma membrane (By similarity). After PMA stimulation, GLRX3 and
CC       PRKCQ/PKC-theta translocate to a more extended submembrane area (By
CC       similarity). In the Z line, found associated with CSRP3 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9CQM9}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, spleen, testis and, to a lower
CC       extent, in thymus and peripheral blood leukocytes. Weakly expressed in
CC       lung, placenta, colon and small intestine.
CC   -!- DOMAIN: The thioredoxin domain lacks the two redox-active cysteines.
CC       This strongly suggests that it lacks thioredoxin activity.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: Silencing of Grx3 in HeLa cells decreases the activities
CC       of several cytosolic Fe/S proteins, such as ACO1, a major component of
CC       post-transcriptional iron regulation. As a consequence, Grx3-depleted
CC       cells show decreased levels of ferritin and increased levels of
CC       transferrin receptor, features characteristic of cellular iron
CC       starvation (PubMed:23615448). {ECO:0000305|PubMed:23615448}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF118649; AAF28841.1; -; mRNA.
DR   EMBL; AF118652; AAF28844.1; -; mRNA.
DR   EMBL; AJ010841; CAA09375.1; -; mRNA.
DR   EMBL; AK022131; BAG51067.1; -; mRNA.
DR   EMBL; AK021926; BAG51059.1; -; mRNA.
DR   EMBL; AL139123; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49152.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49154.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49155.1; -; Genomic_DNA.
DR   EMBL; BC005289; AAH05289.1; -; mRNA.
DR   EMBL; BC014372; AAH14372.2; -; mRNA.
DR   CCDS; CCDS7661.1; -.
DR   RefSeq; NP_001186797.1; NM_001199868.1.
DR   RefSeq; NP_006532.2; NM_006541.4.
DR   PDB; 2DIY; NMR; -; A=1-117.
DR   PDB; 2WZ9; X-ray; 1.55 A; A=1-125.
DR   PDB; 2YAN; X-ray; 1.90 A; A/B=232-334.
DR   PDB; 3ZYW; X-ray; 1.84 A; A/B=130-232.
DR   PDBsum; 2DIY; -.
DR   PDBsum; 2WZ9; -.
DR   PDBsum; 2YAN; -.
DR   PDBsum; 3ZYW; -.
DR   BMRB; O76003; -.
DR   SMR; O76003; -.
DR   BioGRID; 115793; 156.
DR   CORUM; O76003; -.
DR   DIP; DIP-31306N; -.
DR   IntAct; O76003; 117.
DR   MINT; O76003; -.
DR   STRING; 9606.ENSP00000357633; -.
DR   iPTMnet; O76003; -.
DR   MetOSite; O76003; -.
DR   PhosphoSitePlus; O76003; -.
DR   SwissPalm; O76003; -.
DR   BioMuta; GLRX3; -.
DR   REPRODUCTION-2DPAGE; IPI00008552; -.
DR   CPTAC; CPTAC-206; -.
DR   CPTAC; CPTAC-207; -.
DR   EPD; O76003; -.
DR   jPOST; O76003; -.
DR   MassIVE; O76003; -.
DR   MaxQB; O76003; -.
DR   PaxDb; O76003; -.
DR   PeptideAtlas; O76003; -.
DR   PRIDE; O76003; -.
DR   ProteomicsDB; 50341; -.
DR   Antibodypedia; 32521; 358 antibodies.
DR   Ensembl; ENST00000331244; ENSP00000330836; ENSG00000108010.
DR   Ensembl; ENST00000368644; ENSP00000357633; ENSG00000108010.
DR   Ensembl; ENST00000481034; ENSP00000435445; ENSG00000108010.
DR   GeneID; 10539; -.
DR   KEGG; hsa:10539; -.
DR   UCSC; uc001lkm.3; human.
DR   CTD; 10539; -.
DR   DisGeNET; 10539; -.
DR   GeneCards; GLRX3; -.
DR   HGNC; HGNC:15987; GLRX3.
DR   HPA; ENSG00000108010; Low tissue specificity.
DR   MIM; 612754; gene.
DR   neXtProt; NX_O76003; -.
DR   OpenTargets; ENSG00000108010; -.
DR   PharmGKB; PA162389829; -.
DR   VEuPathDB; HostDB:ENSG00000108010.11; -.
DR   eggNOG; KOG0911; Eukaryota.
DR   GeneTree; ENSGT00550000075030; -.
DR   HOGENOM; CLU_026126_12_2_1; -.
DR   InParanoid; O76003; -.
DR   OMA; CGQMNEV; -.
DR   OrthoDB; 1449534at2759; -.
DR   PhylomeDB; O76003; -.
DR   TreeFam; TF314151; -.
DR   PathwayCommons; O76003; -.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   BioGRID-ORCS; 10539; 222 hits in 1001 CRISPR screens.
DR   ChiTaRS; GLRX3; human.
DR   EvolutionaryTrace; O76003; -.
DR   GeneWiki; GLRX3; -.
DR   GenomeRNAi; 10539; -.
DR   Pharos; O76003; Tbio.
DR   PRO; PR:O76003; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; O76003; protein.
DR   Bgee; ENSG00000108010; Expressed in testis and 236 other tissues.
DR   ExpressionAtlas; O76003; baseline and differential.
DR   Genevisible; O76003; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IDA:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IBA:GO_Central.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISS:UniProtKB.
DR   GO; GO:0097428; P:protein maturation by iron-sulfur cluster transfer; IDA:UniProtKB.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; ISS:UniProtKB.
DR   CDD; cd03028; GRX_PICOT_like; 2.
DR   Gene3D; 3.40.30.10; -; 3.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR033658; GRX_PICOT-like.
DR   InterPro; IPR004480; Monothiol_GRX-rel.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR10293; PTHR10293; 1.
DR   Pfam; PF00462; Glutaredoxin; 2.
DR   Pfam; PF00085; Thioredoxin; 1.
DR   SUPFAM; SSF52833; SSF52833; 3.
DR   TIGRFAMs; TIGR00365; TIGR00365; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 2.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; Iron;
KW   Iron-sulfur; Metal-binding; Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   CHAIN           2..335
FT                   /note="Glutaredoxin-3"
FT                   /id="PRO_0000120019"
FT   DOMAIN          2..117
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   DOMAIN          144..236
FT                   /note="Glutaredoxin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00686"
FT   DOMAIN          237..335
FT                   /note="Glutaredoxin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00686"
FT   METAL           159
FT                   /note="Iron-sulfur (2Fe-2S); shared with dimeric partner"
FT                   /evidence="ECO:0000305|PubMed:20226171,
FT                   ECO:0000305|PubMed:27519415"
FT   METAL           261
FT                   /note="Iron-sulfur (2Fe-2S); shared with dimeric partner"
FT                   /evidence="ECO:0000305|PubMed:20226171,
FT                   ECO:0000305|PubMed:27519415"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         120
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         21
FT                   /note="Q -> H (in dbSNP:rs13991)"
FT                   /evidence="ECO:0000269|PubMed:10636891,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_016875"
FT   VARIANT         123
FT                   /note="P -> S (in dbSNP:rs2274217)"
FT                   /evidence="ECO:0000269|PubMed:10636891,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_016876"
FT   MUTAGEN         159
FT                   /note="C->S: Loss of 2Fe-2S-binding; when associated with
FT                   S-261. Loss of 2Fe-2S-binding and interaction with BOLA2;
FT                   when associated with 197-D-A-198."
FT                   /evidence="ECO:0000269|PubMed:20226171,
FT                   ECO:0000269|PubMed:27519415"
FT   MUTAGEN         197..198
FT                   /note="WP->DA: Loss of 2Fe-2S-binding and interaction with
FT                   BOLA2; when associated with S-159."
FT                   /evidence="ECO:0000269|PubMed:27519415"
FT   MUTAGEN         261
FT                   /note="C->S: Loss of 2Fe-2S-binding; when associated with
FT                   S-159. Loss of 2Fe-2S-binding and interaction with BOLA2;
FT                   when associated with 299-D-A-300."
FT                   /evidence="ECO:0000269|PubMed:20226171,
FT                   ECO:0000269|PubMed:27519415"
FT   MUTAGEN         299..300
FT                   /note="WP->DA: Loss of 2Fe-2S-binding and interaction with
FT                   BOLA2; when associated with S-261."
FT                   /evidence="ECO:0000269|PubMed:27519415"
FT   CONFLICT        2
FT                   /note="A -> E (in Ref. 2; CAA09375)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67
FT                   /note="K -> R (in Ref. 3; BAG51067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="I -> T (in Ref. 3; BAG51059)"
FT                   /evidence="ECO:0000305"
FT   STRAND          13..16
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   HELIX           19..28
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   TURN            29..31
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   STRAND          34..39
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   HELIX           44..59
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   STRAND          63..69
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   TURN            70..72
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   HELIX           74..79
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   STRAND          84..92
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   STRAND          95..103
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   HELIX           105..115
FT                   /evidence="ECO:0007744|PDB:2WZ9"
FT   HELIX           133..141
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   STRAND          143..152
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   STRAND          154..159
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           160..171
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   STRAND          177..180
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           181..183
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           185..195
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   STRAND          202..205
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   STRAND          208..211
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           213..221
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           225..228
FT                   /evidence="ECO:0007744|PDB:3ZYW"
FT   HELIX           233..243
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   STRAND          245..254
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   STRAND          256..259
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   HELIX           263..273
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   STRAND          279..282
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   HELIX           283..285
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   HELIX           287..297
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   STRAND          304..307
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   STRAND          310..313
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   HELIX           315..323
FT                   /evidence="ECO:0007744|PDB:2YAN"
FT   HELIX           327..331
FT                   /evidence="ECO:0007744|PDB:2YAN"
SQ   SEQUENCE   335 AA;  37432 MW;  46D644413D9EDFDA CRC64;
     MAAGAAEAAV AAVEEVGSAG QFEELLRLKA KSLLVVHFWA PWAPQCAQMN EVMAELAKEL
     PQVSFVKLEA EGVPEVSEKY EISSVPTFLF FKNSQKIDRL DGAHAPELTK KVQRHASSGS
     FLPSANEHLK EDLNLRLKKL THAAPCMLFM KGTPQEPRCG FSKQMVEILH KHNIQFSSFD
     IFSDEEVRQG LKAYSSWPTY PQLYVSGELI GGLDIIKELE ASEELDTICP KAPKLEERLK
     VLTNKASVML FMKGNKQEAK CGFSKQILEI LNSTGVEYET FDILEDEEVR QGLKAYSNWP
     TYPQLYVKGE LVGGLDIVKE LKENGELLPI LRGEN
//
